---
title: Bacteriology
order: 1
category: Microbiology
status: complete
last_updated: '2025-01-09'
---

# Bacteriology

## Overview

Bacteriology is the study of bacteria, single-celled prokaryotic microorganisms that lack a nucleus and membrane-bound organelles. Bacteria are ubiquitous in nature and play essential roles in human health, disease, and the environment. Understanding bacterial structure, physiology, pathogenesis, and antimicrobial susceptibility is fundamental to clinical medicine and public health.

Bacteria range from 0.2-10 micrometers in size and can be classified by shape (cocci, bacilli, spirochetes), Gram stain characteristics, oxygen requirements, and biochemical properties. While many bacteria are commensal or beneficial, pathogenic bacteria cause significant morbidity and mortality worldwide through diverse virulence mechanisms.

### Key Characteristics

**Prokaryotic Features**:
- No nucleus or membrane-bound organelles
- Single circular chromosome in nucleoid region
- 70S ribosomes (50S + 30S subunits)
- Cell wall containing peptidoglycan
- Plasmids for additional genetic material

**Bacterial Shapes**:
- **Cocci**: Spherical (Staphylococcus, Streptococcus)
- **Bacilli**: Rod-shaped (E. coli, Bacillus)
- **Spirochetes**: Spiral (Treponema, Borrelia)
- **Pleomorphic**: Variable shape (Mycoplasma)

## Classification and Structure

### Gram Staining

The Gram stain is the most important bacterial classification method, differentiating bacteria based on cell wall structure:

**Gram-Positive Bacteria**:
- **Thick peptidoglycan layer** (20-80 nm)
- Teichoic acids in cell wall
- No outer membrane
- Retains crystal violet stain (purple)
- Examples: Staphylococcus, Streptococcus, Clostridium, Bacillus

**Gram-Negative Bacteria**:
- **Thin peptidoglycan layer** (2-3 nm)
- Outer membrane with lipopolysaccharide (LPS/endotoxin)
- Periplasmic space
- Appears pink after safranin counterstain
- Examples: E. coli, Pseudomonas, Neisseria, Salmonella

**Acid-Fast Bacteria**:
- Mycolic acid-rich cell wall
- Resistant to Gram staining
- Requires Ziehl-Neelsen or Auramine-Rhodamine stain
- Examples: Mycobacterium tuberculosis, M. leprae

### Bacterial Cell Structure

**Essential Components**:

1. **Cell Wall**:
   - Maintains cell shape and osmotic integrity
   - Target for β-lactam antibiotics
   - Peptidoglycan cross-linked by transpeptidases

2. **Cell Membrane**:
   - Phospholipid bilayer
   - Energy generation via electron transport chain
   - Nutrient transport and waste excretion

3. **Cytoplasm**:
   - Contains ribosomes, enzymes, and metabolites
   - Site of protein synthesis and metabolism

4. **Nucleoid**:
   - Contains circular chromosome
   - No nuclear membrane
   - DNA supercoiled and associated with proteins

**Optional Structures**:

1. **Capsule**:
   - Polysaccharide or protein layer
   - Antiphagocytic (virulence factor)
   - Examples: S. pneumoniae, K. pneumoniae

2. **Flagella**:
   - Locomotion organelles
   - Composed of flagellin protein
   - Monotrichous, lophotrichous, peritrichous arrangements

3. **Pili/Fimbriae**:
   - Hair-like surface appendages
   - Adherence to host cells
   - Sex pili for conjugation (genetic transfer)

4. **Spores**:
   - Dormant, resistant survival forms
   - Resist heat, desiccation, chemicals
   - Produced by Bacillus and Clostridium species

## Pathophysiology

### Bacterial Virulence Factors

**Adhesion Factors**:
- Pili and fimbriae for attachment to host cells
- Surface proteins (M protein of S. pyogenes)
- Enable colonization and prevent clearance

**Invasion Factors**:
- Enzymes degrading tissue barriers (hyaluronidase, collagenase)
- Invasins facilitating cellular entry
- IgA proteases cleaving mucosal antibodies

**Toxins**:

1. **Exotoxins** (secreted proteins):
   - **A-B toxins**: Binding (B) and active (A) subunits
     - Diphtheria toxin: Inhibits protein synthesis
     - Cholera toxin: Activates adenylate cyclase, causing secretory diarrhea
     - Tetanus toxin: Blocks inhibitory neurotransmitters (spastic paralysis)
     - Botulinum toxin: Blocks acetylcholine release (flaccid paralysis)

   - **Cytotoxins**: Direct cell damage
     - Hemolysins: Lyse red blood cells
     - Leukocidins: Destroy white blood cells

   - **Superantigens**: Massive T-cell activation
     - Toxic shock syndrome toxin (TSST-1)
     - Staphylococcal enterotoxins

2. **Endotoxin** (LPS of gram-negative bacteria):
   - Lipid A component triggers inflammatory response
   - Activates complement, coagulation cascades
   - Causes fever, septic shock, DIC

**Immune Evasion**:
- Capsules resist phagocytosis
- Protein A binds IgG Fc region (S. aureus)
- Antigenic variation (N. gonorrhoeae)
- Intracellular survival (Mycobacterium, Listeria)
- Biofilm formation

### Bacterial Pathogenesis Mechanisms

**Steps in Infection**:
1. **Transmission**: Contact, droplet, airborne, vector-borne, fecal-oral
2. **Adherence**: Attachment to host epithelial surfaces
3. **Invasion**: Entry into tissues (some bacteria remain extracellular)
4. **Multiplication**: Bacterial replication in host
5. **Evasion**: Circumventing host immune defenses
6. **Damage**: Direct toxin effects or immune-mediated injury

**Host Defense Mechanisms**:
- Physical barriers (skin, mucosa, ciliary clearance)
- Innate immunity (complement, phagocytes, NK cells)
- Adaptive immunity (antibodies, T cells)
- Normal flora competitive exclusion

## Clinical Presentation

### Gram-Positive Cocci

**Staphylococcus aureus**:
- Catalase-positive, coagulase-positive
- Clusters on Gram stain ("grape clusters")
- **Diseases**: Skin infections (impetigo, cellulitis, abscesses), pneumonia, endocarditis, osteomyelitis, toxic shock syndrome, food poisoning
- **Virulence factors**: Protein A, hemolysins, coagulase, enterotoxins, TSST-1
- **MRSA**: Methicillin-resistant (mecA gene encoding altered PBP2a)

**Staphylococcus epidermidis**:
- Coagulase-negative
- Normal skin flora
- **Diseases**: Catheter-related infections, prosthetic device infections
- Biofilm formation on foreign materials

**Staphylococcus saprophyticus**:
- Coagulase-negative
- **Disease**: UTI in young sexually active women
- Urease-positive

**Streptococcus pyogenes** (Group A Strep):
- β-hemolytic, bacitracin-sensitive
- **Diseases**: Pharyngitis ("strep throat"), scarlet fever, impetigo, erysipelas, cellulitis, necrotizing fasciitis
- **Sequelae**: Rheumatic fever, post-streptococcal glomerulonephritis
- **Virulence factors**: M protein, streptolysin O/S, streptokinase, hyaluronidase

**Streptococcus pneumoniae** (Pneumococcus):
- α-hemolytic, optochin-sensitive, bile-soluble
- Lancet-shaped diplococci with capsule
- **Diseases**: Pneumonia (lobar), meningitis, otitis media, sinusitis
- **Prevention**: 13-valent conjugate (PCV13) and 23-valent polysaccharide (PPSV23) vaccines

**Streptococcus agalactiae** (Group B Strep):
- β-hemolytic, bacitracin-resistant
- **Diseases**: Neonatal sepsis and meningitis, maternal postpartum infections
- **Screening**: Pregnant women at 35-37 weeks; intrapartum antibiotic prophylaxis

**Enterococcus** (E. faecalis, E. faecium):
- Part of normal intestinal flora
- **Diseases**: UTI, endocarditis, intra-abdominal infections
- Intrinsically resistant to cephalosporins
- VRE: Vancomycin-resistant enterococci

### Gram-Positive Bacilli

**Bacillus anthracis**:
- Spore-forming, aerobic
- **Disease**: Anthrax (cutaneous, inhalational, GI)
- **Virulence**: Anthrax toxin, poly-D-glutamate capsule
- Bioterrorism agent

**Clostridium perfringens**:
- Spore-forming, anaerobic
- **Diseases**: Gas gangrene (myonecrosis), food poisoning
- α-toxin (lecithinase) causes hemolysis and tissue necrosis

**Clostridium tetani**:
- Spore-forming, anaerobic
- **Disease**: Tetanus (lockjaw)
- Tetanospasmin toxin blocks inhibitory neurotransmitters
- **Prevention**: DTaP/Tdap vaccine

**Clostridium botulinum**:
- Spore-forming, anaerobic
- **Diseases**: Botulism (foodborne, infant, wound)
- Botulinum toxin blocks acetylcholine release
- **Treatment**: Antitoxin, supportive care

**Clostridium difficile**:
- Spore-forming, anaerobic
- **Disease**: Pseudomembranous colitis (antibiotic-associated diarrhea)
- Toxins A (enterotoxin) and B (cytotoxin)
- **Treatment**: Vancomycin or fidaxomicin

**Listeria monocytogenes**:
- Facultative intracellular, motile at 25°C
- **Diseases**: Meningitis, bacteremia in immunocompromised, neonatal sepsis
- Transmitted via contaminated dairy, deli meats
- "Tumbling motility" on wet mount

**Corynebacterium diphtheriae**:
- Club-shaped with metachromatic granules
- **Disease**: Diphtheria (pseudomembranous pharyngitis)
- Diphtheria toxin (ADP-ribosylates EF-2, inhibiting protein synthesis)
- **Prevention**: DTaP/Tdap vaccine

### Gram-Negative Cocci

**Neisseria meningitidis** (Meningococcus):
- Diplococci, oxidase-positive
- **Diseases**: Meningitis, meningococcemia with petechial rash, Waterhouse-Friderichsen syndrome
- **Prevention**: Conjugate vaccines (MenACWY, MenB)

**Neisseria gonorrhoeae** (Gonococcus):
- Diplococci, oxidase-positive
- **Diseases**: Gonorrhea (urethritis, cervicitis), PID, disseminated gonococcal infection, neonatal conjunctivitis
- No vaccine available due to antigenic variation

### Gram-Negative Bacilli (Enteric)

**Escherichia coli**:
- Lactose-fermenting, oxidase-negative
- Normal gut flora
- **Pathogenic strains**:
  - **ETEC**: Traveler's diarrhea (heat-labile and heat-stable toxins)
  - **EPEC**: Pediatric diarrhea
  - **EHEC** (O157:H7): Hemorrhagic colitis, HUS (Shiga-like toxin)
  - **EIEC**: Invasive dysentery
  - **EAEC**: Persistent diarrhea
- **Extraintestinal diseases**: UTI, neonatal meningitis, sepsis

**Salmonella** (non-typhoidal):
- Non-lactose-fermenting, H2S-positive
- **Diseases**: Gastroenteritis, bacteremia
- Transmitted via poultry, eggs, reptiles

**Salmonella typhi**:
- **Disease**: Typhoid fever (enteric fever)
- Rose spots on abdomen, constipation initially
- Carried in gallbladder (chronic carriers)

**Shigella**:
- Non-lactose-fermenting, non-motile
- **Disease**: Bacillary dysentery (bloody diarrhea)
- Shiga toxin inhibits protein synthesis
- Very low infectious dose (10-100 organisms)

**Yersinia enterocolitica**:
- **Disease**: Acute diarrhea, pseudoappendicitis (mesenteric adenitis)
- Associated with contaminated milk, pork

**Campylobacter jejuni**:
- Comma or S-shaped, oxidase-positive, grows at 42°C
- **Disease**: Bloody diarrhea
- Associated with undercooked poultry
- **Complication**: Guillain-Barré syndrome

### Gram-Negative Bacilli (Respiratory)

**Haemophilus influenzae**:
- Requires factors V (NAD) and X (hemin)
- **Diseases**: Meningitis, epiglottitis, otitis media, pneumonia
- Type B capsule most virulent
- **Prevention**: Hib conjugate vaccine

**Bordetella pertussis**:
- **Disease**: Whooping cough (pertussis)
- Three stages: catarrhal, paroxysmal, convalescent
- Pertussis toxin (ADP-ribosylates Gi)
- **Prevention**: DTaP/Tdap vaccine

**Legionella pneumophila**:
- Intracellular, requires charcoal yeast extract with iron and cysteine
- **Disease**: Legionnaires' disease (severe pneumonia)
- Transmitted via water aerosols (cooling towers, hot tubs)
- Detected by urinary antigen test

**Pseudomonas aeruginosa**:
- Obligate aerobe, oxidase-positive, produces pyocyanin (blue-green pigment)
- **Diseases**: Pneumonia in CF patients, burn infections, hot tub folliculitis, malignant otitis externa, UTI, osteomyelitis
- Resistant to many antibiotics (efflux pumps, biofilms)

**Klebsiella pneumoniae**:
- Lactose-fermenting, large mucoid capsule
- **Diseases**: Pneumonia ("currant jelly" sputum), UTI, sepsis
- Associated with alcoholics and diabetics
- ESBL and carbapenemase resistance

### Zoonotic Bacteria

**Brucella**:
- **Disease**: Brucellosis (undulant fever)
- Transmitted via unpasteurized dairy
- Intracellular pathogen

**Francisella tularensis**:
- **Disease**: Tularemia (rabbit fever)
- Ulceroglandular, pneumonic forms
- Highly infectious (bioterrorism agent)

**Yersinia pestis**:
- **Disease**: Plague (bubonic, pneumonic, septicemic)
- Transmitted by fleas from rodents
- Bioterrorism agent

**Pasteurella multocida**:
- **Disease**: Cellulitis from animal bites (cats, dogs)
- Rapid onset after bite

### Intracellular Bacteria

**Mycobacterium tuberculosis**:
- Acid-fast, aerobic, slow-growing (6-8 weeks)
- **Disease**: Tuberculosis (pulmonary, extrapulmonary)
- Cord factor (virulence), sulfatides (intracellular survival)
- **Diagnosis**: Acid-fast stain, culture, IGRA, tuberculin skin test
- **Treatment**: RIPE therapy (rifampin, isoniazid, pyrazinamide, ethambutol)

**Mycobacterium leprae**:
- Acid-fast, cannot be cultured in vitro
- **Disease**: Leprosy (Hansen's disease)
- Tuberculoid vs lepromatous forms
- Grows in cool areas (extremities, nose)

**Chlamydia trachomatis**:
- Obligate intracellular, cannot make ATP
- **Diseases**: Urethritis, cervicitis, PID, lymphogranuloma venereum (LGV), trachoma (blindness)
- Elementary body (infectious) and reticulate body (replicative)

**Chlamydia pneumoniae**:
- **Disease**: Atypical pneumonia ("walking pneumonia")
- Associated with atherosclerosis

**Rickettsia rickettsii**:
- Obligate intracellular, transmitted by ticks
- **Disease**: Rocky Mountain spotted fever
- Rash starts on wrists/ankles, spreads centrally

**Coxiella burnetii**:
- Obligate intracellular
- **Disease**: Q fever (pneumonia, hepatitis)
- Spore-like form resists heat and desiccation
- Transmitted via inhalation (no arthropod vector needed)

### Spirochetes

**Treponema pallidum**:
- Thin, spiral bacterium, cannot be cultured
- **Disease**: Syphilis (primary, secondary, tertiary)
- **Diagnosis**: Dark-field microscopy, VDRL/RPR (nontreponemal), FTA-ABS (treponemal)

**Borrelia burgdorferi**:
- Transmitted by Ixodes ticks
- **Disease**: Lyme disease
- Erythema migrans (bull's-eye rash), arthritis, cardiac/neurologic complications

**Leptospira interrogans**:
- **Disease**: Leptospirosis (Weil's disease)
- Transmitted via water contaminated with animal urine
- Jaundice, renal failure, meningitis

## Diagnosis

### Laboratory Methods

**Microscopy**:
- Gram stain for initial classification
- Acid-fast stain for Mycobacterium
- Dark-field microscopy for spirochetes
- Direct examination of clinical specimens

**Culture**:
- Blood agar, chocolate agar, MacConkey agar
- Enriched media for fastidious organisms
- Anaerobic culture for Clostridium, Bacteroides
- Selective/differential media for identification

**Biochemical Tests**:
- Catalase test (Staphylococcus vs Streptococcus)
- Coagulase test (S. aureus vs coagulase-negative Staph)
- Oxidase test (Pseudomonas, Neisseria)
- Urease, indole, citrate tests for Enterobacteriaceae

**Molecular Methods**:
- PCR for rapid detection and identification
- NAAT for C. trachomatis, N. gonorrhoeae
- 16S rRNA gene sequencing
- Whole genome sequencing for epidemiology

**Serologic Tests**:
- Antibody detection (IgM for acute, IgG for chronic)
- Antigen detection (S. pneumoniae, Legionella urinary antigens)
- Latex agglutination tests

**Antimicrobial Susceptibility Testing**:
- Disk diffusion (Kirby-Bauer)
- Broth microdilution (MIC determination)
- E-test strips
- Automated systems

## Treatment

### Antimicrobial Agents

**β-Lactam Antibiotics**:

1. **Penicillins**:
   - **Mechanism**: Inhibit cell wall synthesis by binding penicillin-binding proteins (transpeptidases)
   - **Natural penicillins** (Penicillin G, V): Streptococcus, Treponema
   - **Antistaphylococcal** (Nafcillin, oxacillin): MSSA
   - **Aminopenicillins** (Ampicillin, amoxicillin): Extended gram-negative coverage
   - **Extended-spectrum** (Piperacillin): Pseudomonas
   - **β-lactamase inhibitor combinations**: Augmentin, Unasyn, Zosyn

2. **Cephalosporins**:
   - **1st generation** (Cefazolin): Gram-positive, surgical prophylaxis
   - **2nd generation** (Cefuroxime): Enhanced gram-negative
   - **3rd generation** (Ceftriaxone, cefotaxime): Excellent gram-negative, meningitis
   - **4th generation** (Cefepime): Pseudomonas coverage
   - **5th generation** (Ceftaroline): MRSA coverage

3. **Carbapenems** (Imipenem, meropenem, ertapenem):
   - Broadest spectrum β-lactams
   - Reserved for multidrug-resistant organisms
   - Not inactivated by ESBLs

**Glycopeptides** (Vancomycin, teicoplanin):
- Inhibit cell wall synthesis (different mechanism than β-lactams)
- MRSA, C. difficile (oral vancomycin)
- Requires monitoring of trough levels
- Red man syndrome with rapid infusion

**Aminoglycosides** (Gentamicin, tobramycin, amikacin):
- Inhibit 30S ribosomal subunit (protein synthesis)
- Synergistic with β-lactams
- Nephrotoxic and ototoxic
- Requires therapeutic drug monitoring

**Macrolides** (Azithromycin, clarithromycin, erythromycin):
- Inhibit 50S ribosomal subunit
- Atypical pneumonia, Mycoplasma, Chlamydia
- Good oral bioavailability

**Tetracyclines** (Doxycycline, tetracycline):
- Inhibit 30S ribosomal subunit
- Broad spectrum, intracellular organisms
- Rickettsiae, Borrelia, Chlamydia
- Avoid in pregnancy and children <8 years

**Fluoroquinolones** (Ciprofloxacin, levofloxacin, moxifloxacin):
- Inhibit DNA gyrase and topoisomerase IV
- Excellent bioavailability
- Gram-negative coverage, respiratory quinolones for pneumonia
- Tendon rupture risk, avoid in pregnancy

**Sulfonamides and Trimethoprim**:
- Inhibit folate synthesis (sequential blockade)
- TMP-SMX: PCP prophylaxis, UTI, MRSA
- Allergic reactions common

**Metronidazole**:
- DNA damage via free radicals
- Anaerobes (Bacteroides, Clostridium), protozoal infections
- Disulfiram-like reaction with alcohol

**Anti-Tuberculosis Agents**:
- **Isoniazid**: Inhibits mycolic acid synthesis
- **Rifampin**: Inhibits RNA polymerase
- **Pyrazinamide**: Disrupts membrane transport
- **Ethambutol**: Inhibits arabinosyl transferase
- Combination therapy to prevent resistance

### Antibiotic Resistance Mechanisms

**Enzymatic Inactivation**:
- β-lactamases (penicillinases, ESBLs, carbapenemases)
- Aminoglycoside-modifying enzymes
- Chloramphenicol acetyltransferase

**Target Modification**:
- Altered PBPs (MRSA with PBP2a)
- Ribosomal methylation (macrolide resistance)
- Altered DNA gyrase (quinolone resistance)

**Decreased Permeability**:
- Porin loss in gram-negatives
- Thickened cell wall

**Efflux Pumps**:
- Active transport out of cell
- Tetracycline, fluoroquinolone resistance
- Multidrug efflux pumps in Pseudomonas

**Bypass Pathways**:
- Alternative metabolic pathway (sulfonamide resistance)

**Genetic Mechanisms**:
- Chromosomal mutations
- Horizontal gene transfer (plasmids, transposons, bacteriophages)
- Conjugation, transformation, transduction

## Prevention

### Infection Control

**Standard Precautions**:
- Hand hygiene (most important)
- Personal protective equipment (PPE)
- Safe injection practices
- Respiratory hygiene

**Transmission-Based Precautions**:
- **Contact**: MRSA, VRE, C. difficile
- **Droplet**: Pertussis, meningococcal disease, influenza
- **Airborne**: Tuberculosis, measles, varicella

**Sterilization and Disinfection**:
- Autoclaving for heat-resistant items
- High-level disinfection for semicritical items
- Proper cleaning and disinfection protocols

### Vaccination

**Bacterial Vaccines**:
- **DTaP/Tdap**: Diphtheria, tetanus, pertussis
- **Hib**: H. influenzae type b conjugate
- **Pneumococcal**: PCV13 (conjugate), PPSV23 (polysaccharide)
- **Meningococcal**: MenACWY, MenB
- **BCG**: Bacille Calmette-Guérin (not routinely used in US)

### Antimicrobial Stewardship

**Principles**:
- Appropriate selection, dosing, and duration
- De-escalation based on culture results
- Avoiding unnecessary broad-spectrum use
- Monitoring for adverse effects and resistance

## Key Points

1. Gram stain differentiates bacteria by cell wall structure and guides initial therapy
2. Virulence factors (toxins, capsules, adhesins) determine pathogenic potential
3. Specific bacterial pathogens have characteristic clinical presentations and complications
4. Culture and susceptibility testing guide definitive antimicrobial therapy
5. Antibiotic resistance is an increasing threat requiring stewardship efforts
6. Vaccines prevent many serious bacterial infections
7. Infection control practices reduce healthcare-associated infections
8. Understanding bacterial pathogenesis informs treatment and prevention strategies
9. Intracellular bacteria require specific antimicrobials that penetrate cells
10. Spore-forming bacteria require special sterilization and disinfection methods

## References

1. Murray PR, et al. Medical Microbiology. 9th ed. Elsevier; 2021.
2. Brooks GF, et al. Jawetz, Melnick, & Adelberg's Medical Microbiology. 28th ed. McGraw-Hill; 2019.
3. Kasper DL, et al. Harrison's Principles of Internal Medicine. 21st ed. McGraw-Hill; 2022.
4. Centers for Disease Control and Prevention. Antibiotic Resistance Threats Report. 2019.
5. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 2023.
6. Mandell GL, et al. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Elsevier; 2020.
